case_images: PMC11787631_01
case_images: (a). Enhanced CT (arterial phase) showed that the tumor was located in the right posterior lobe with uneven enhancement. Fig. 1b. Enhanced CT (venous phase) showed that the tumor was further enhanced in the venous phase, and the right branch of the portal vein was invaded.
case_images: gr1.jpg
case_images: PMC11787631_01_gr1.jpg
case_images: fig1
case_images: The imaging examination revealed the presence of a tumor measuring approximately 4.9*3.8*4.0cm in the right posterior lobe of the liver, accompanied by invasion of the right branch of the portal vein (Fig. 1a and b).
case_images: (a and b). The specimen shows cancerous cells manifest in beam-like and nest-like formations, displaying diverse sizes and morphologies. (Hematoxylin and eosin, x100).
case_images: gr2.jpg
case_images: PMC11787631_01_gr2.jpg
case_images: fig2
case_images: Pathological examination confirmed infiltration by poorly differentiated cancer cells into liver tissue samples obtained from biopsy (Fig. 2a and b).
case_images: (a). Enhanced CT (arterial stage) showed that the tumor was located in the right posterior lobe, with internal iodol deposits and no enhancement. Fig. 3b. Enhanced CT (venous phase) showed that the tumor was located in the right posterior lobe, with internal iodol deposits.
case_images: gr3.jpg
case_images: PMC11787631_01_gr3.jpg
case_images: fig3
case_images: Oxaliplatin, Fluorouracil (TACE/HAIC), followed by initiation of oral Lenvatinib therapy at a daily dose of 12mg. On October 26, 2021, chest, abdomen, and pelvis enhanced CT revealed a significant reduction in liver tumor size and inactivity (Fig. 3a and b), while AFP levels decreased to 49.94ng/ml.
case_images: (a and b). The specimen shows no evidence of cancer, but cell necrosis, accompanied by infiltration of inflammatory cells (Hematoxylin and eosin, x100).
case_images: gr4.jpg
case_images: PMC11787631_01_gr4.jpg
case_images: fig4
case_images: Subsequent histological examination showed that no malignant cells remained (Fig. 4a and b).
case_images: Treatment timeline of this case.
case_images: gr5.jpg
case_images: PMC11787631_01_gr5.jpg
case_images: fig5
case_images: A schematic representation of the treatment timeline is presented below(Fig. 5).